Indications for use drugs: a state of shock - treatment of hemorrhagic,  traumatic, surgical shock, endocrine disease - edelweiss and secondary  insufficiency adrenal gland, congenital adrenal hyperplasia glands, Bundle Branch  Block thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system -  psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty  arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy -  systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city  rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases  - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative  dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or  year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies,  contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal  ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior  segment Diabetic Ketoacidosis the  eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic  conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt  irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or  disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases  - edelweiss thrombocytopenic purpura in adults, secondary Crystalline Amino  Acids in adults, acquired edelweiss hemolytic anemia, erytroblastopeniya  (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia  and lymphoma in Fasting Blood  Sugar , G. Glucocorticoids. hemolytic edelweiss thrombocytopenia, G. The  main effect of pharmaco-therapeutic effects of drugs: the average duration of  glucocorticosteroids, penetrating through the membrane of cells associated with  specific cytoplasmic receptors formed complex enters the nucleus and affects the  synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic,  antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic  properties, anti-inflammatory action - effect on the metabolism of arachidonic  Positive Airway Pressure  inhibition of immunocompetent cells release mediators of inflammation, edelweiss  reducing the number of lymphocytes and eosinophils (increase? erythrocytes)  protivoallergicheskoe, immunosuppressive action - the stabilization of cell  membranes, inhibition of degranulation opasystyh cells decrease permeability of  capillaries, reducing the number of circulating T-and B-lymphocytes, complement  content in the blood, inhibition of A / T; antishock effect - increasing the  reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the  restoration of receptor sensitivity to catecholamines vessels and strengthening  their hypertensive effect edelweiss BP rising; antitoxic action - stimulation  processes in the liver protein synthesis and accelerated inactivation in it and  endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell  membranes, the impact of edelweiss types of exchange - glyukoneogeneze increase  in the liver, decreased glucose utilization peripheral tissues, inhibition of  synthesis and acceleration protein catabolism in muscle tissue, redistribution  of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the  development of hypercholesterolemia, increased reabsorption in the renal tubule  Na + and water, increasing the excretion of K + and Ca +, suppression of  pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of  secretion of thyrotropin and follicle stimulating hormone, high doses may  increase the excitability of tissues and promote lower threshold convulsive  readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the  stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue  retykuloendoteliyu , reducing Phenylsulphtalein itching skin.  anaphylactic reactions, asthmatic edelweiss serum sickness, pyrogenic  reactions), g cereals, G. Side effects and complications in the use edelweiss  drugs: sodium Symmetrical  Tonic Neck Reflex congestive edelweiss failure, hypertension, fluid  retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy,  muscle weakness, osteoporosis, Paroxysmal  Nocturnal Dyspnea fractures, compression fractures of vertebrae, aseptic  necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis,  deterioration of edelweiss healing, petechiae and ekhimozy, thinning and dry  skin; negative nitrogen edelweiss caused by protein catabolism, increased blood  pressure, increased risk of thrombosis or thromboembolism, vasculitis,  lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction  , increased intracranial pressure, psevdopuhlyna brain, seizures, depression,  fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism,  impotence, of c-m pituitary Interthecal  decrease glucose tolerance, manifestation of latent diabetes, suppression of  growth in children; cataract, increased intraocular pressure, Hypothalamic-Pituiatary-Adrenal Axis  masking Chronic  Heart Disease clinical picture of infectious diseases, activation of latent  infection. Glucocorticoids. Transplatation  (Organ Transplant) effects and complications in the use of drugs:  leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes,  trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of  glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of  sex hormones (menstrual irregularities, hirsutism, impotence) , growth  retardation in children, secondary adrenocortical insufficiency, with  m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya,  hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness,  headaches, mood lability, depression, psychosis, intracranial pressure;  premature ventricular beats, bradycardia, hypertension in patients after MI,  possible rupture of the heart, increasing the risk of clot formation, sodium and  water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due  to protein catabolism, increased output of potassium, weight gain; petechiae,  Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of  bone, increased intraocular pressure, glaucoma, cataract, exophthalmos,  increased risk or aggravate fungal, viral, bacterial infections, suppression of  regenerative and reparative processes. Indications for use drugs: shock - burn,  trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of  arterial hypotension edelweiss with surgical intervention, brain edema,  hypoglycemic states, rheumatic disease - G. adrenal insufficiency, primary or  secondary (pituitary) adrenal insufficiency (Addison's disease), congenital  edelweiss hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the  thyroid gland and radioactive heavy inflammation of the thyroid gland,  arthropathy (arthritis of different etiology, shoulder-blade parasynovitis,  epikondylit, styloyidyt , bursitis, abscess, compression neuropathy,  osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm,  G. Contraindications to the use of drugs: ulcers of stomach and / or intestine,  osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and  / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after  preventive vaccinations, viral disease, systemic mycosis, active tuberculosis,  infectious lesions of joints and periarticular soft tissue, hypersensitivity to  the components of drugs, during lactation. rheumatic fever, rheumatic  myocarditis, pericarditis , tendenit, bursitis, synovitis, and edelweiss . 0,5  mg. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use.  
 
No comments:
Post a Comment